Kintara Therapeutics Announces Data Presentation at the 2023 American Association for Cancer Research Annual Meeting April 14, 2023 • 12:00 PM EDT
Kintara Therapeutics to Present Two Posters at the 2023 American Association for Cancer Research Annual Meeting March 15, 2023 • 8:00 AM EDT
Kintara Therapeutics Scheduled to Present at Two Conferences the Week of March 13, 2023 March 10, 2023 • 8:30 AM EST
Kintara Therapeutics Announces Fiscal 2023 Second Quarter Financial Results and Provides Corporate Update February 14, 2023 • 5:00 PM EST
Kintara Therapeutics to Present at the 2023 BIO CEO & Investor Conference January 30, 2023 • 8:00 AM EST
Kintara Therapeutics to Present at the Biotech Showcase Conference on January 10, 2023 January 9, 2023 • 8:30 AM EST
Kintara Therapeutics Receives Orphan Drug Designation for VAL-083 for Treatment of Diffuse Intrinsic Pontine Glioma (DIPG) December 15, 2022 • 8:00 AM EST
Kintara Therapeutics to Participate at the RHK Capital Disruptive Growth Conference on December 5-6, 2022 December 1, 2022 • 8:00 AM EST